Mikhail Blagosklonny is an accomplished scientist, physician, scholar, writer, and professor in medicine and oncology. He took his medical studies at First Pavlov State Medical University of St. Petersburg, where he obtained a Master’s Degree in Internal Medicine and a PhD in Experimental Medicine and Cardiology.
Mikhail began practicing as an associate professor of medicine in New York Medical College, Valhalla in 2002 and later was taken in by Ordway Research Institute as a senior scientist. On the 15th April, 2009, Blagosklonny got a coveted appointment as the Professor of Oncology in Roswell Park Cancer Institute. His research on cancer and its therapies, Biogerontology; mechanism of aging and advocacy on the use of Rapamyclin as a cancer and anti-aging drug to elongate life, are some of the remarkable work he has done in medicine. Read more about Mikhail at LinkedIn
Mikhail Blagosklonny talks of the possible role in aging where he outlines the correlation between a cellular system that control growth of cells, development and aging subject to dynamic external environment with varying factors such as nutrient availability, energy levels, growth factors and physiological stresses. He argues that it relays signals of these changes, from which a regulatory action in growth and metabolism is taken in all eukaryotic cells. Rapamycin has been proven to inhibit growth of cells and therefore can be used in cancer treatment to prevent growth or rejuvenation of cancer cells.
This renowned oncologist and scholar has brought forth more than 270 publication from his research work with over 2500 citations just to show the depth of his work and his passionate desire on ways to eradicate cancer cells.following this, he is a member of the editorial board of Cell Death and Differentiation, an associate editor of cancer Biology and therapy and the Editor in Chief of Oncotarget.
At Roswell Park Cancer Institute, Mikhail Blagosklonny currently holds the prestigious position of a professor of oncology where he continues to teach on cell growth and development. He also does his research while at the center and is continually writing more publications on the same.
Under the leadership of able its chief editors Andrei Gudkov from Roswell Park Cancer Institute and Blagosklonny Mikhail, Oncotarget is a peer-review medical journal that covers research in all disciplines. The reviews are done on a weekly basing and are open to access. The famous journal published by Impact Journals was brought to life in 2010 with oncology in mind but its success saw other disciplines introduced. Other disciplines covered by the journal include Cardiology, Pharmacology, Neuroscience, Endocrinology, Metabolism and Cell Biology among others. The weekly releases are normally printed to meet special demands. In its presentation, the journal follows Index Medicus, Scopus and Science Citations in creating abstract and in indexing.
Working towards a vision of spreading scientific results broadly and making such results readily available, the journal has seen the impact factor (IF) grow from 4.784 with a coverage of 493 cities in 2011 grow to 5.008 and 10452 cities covered in 2016. An analysis of the Web of Science Core Collection done in January of 2017 showed that the journal would experience a rise in the Thomson Reuters 2016 for the Impact Factor during the next summer. Download output styles at Endnote.com
Other drivers of the journal include to capitalize on the impact of research through insightful assessment, to bring together knowledge from different specialties and biomedical fields, to try eliminate certain diseases through research in clinical and basic sciences and to allow brilliant innovations to spread the climax of it all being a life without illness. The journal has prominent scientists sit in its publishing board including Carlo Croce and Andrew Schally; a onetime Nobel Prize winner. Other notable members include Alexander Varshavsky, Stephen J. Elledge, Michael N. Hall and Bert Vogelstein who won the most prestigious award ever- The Breakthrough price.
February 9th, 2017 Update: If you’re interested in a behind the scenes look at what makes Dherbs.com tick, check out the Ideamensch interview with CEO AD Dolphin. He’s got some very interesting ideas about health, and running a company in 2017. Be sure to read about his plans for the future with Dherbs.com here.
Let’s face it, weight loss is hard and we often feel like there is no easy solution. We often embarrassed by our weight and try many different diets only for them not to work. Recently, Pastor Hosea Collins decided to go on the Dherbs.com diet and see how it work for him.
His church decided to have a Biggest Loser type weight loss challenge in order to raise money for their youth mission trips. While Pastor Collins decided to participate every year, he never really got into it. He had been overweight for over 20 years. He finally stepped on the scale and looked at his weight and realized for his wife and children that he had to do something in order to lose weight.
Pastor Collins was introduced to Dherbs by one of his parishioners. She showed him how the system works and how it could help benefit his weight loss. He began with the 20 day full body cleanse which is eating raw vegetables and fruit.
At his weigh in for the church, Pastor Collins discovered that he has lost 27 pounds with the Dherbs.com program and has goals to lose one hundred more pounds. He said that he would highly recommend that anyone who was looking to lose weight and wanted to do so in a healthy manner should do so with Dherbs. With an all natural approach, Dherbs.com can help your body to replenish the vitamins and minerals that it so desperately needs and can help to kick start your metabolism. Follow Dherbs.com on social media including Tumblr, or their business page on LinkedIn.